Join us at PCR London Valves 2025
London, 16-18 November 2025, ExCeL London
Attend engaging Edwards Lifesciences symposia featuring live cases, on-stage simulators, and expert clinical insights.
Symposia
Symposia
Symposium
Symposia
From Repair To Replacement: A Portfolio Of Options For Your Mitral And Tricuspid Regurgitation Patients
Sunday 16 November 2025 | 12:10-13:40 | The Forum
Anchorperson: Ee Ling Heng
Spokesperson: Philipp Lurz
Discussants: Niklas Schofer, Jennifer von Stein, Jonathan Michel, Dabit Arzamendi, Federico De Marco, Björn Goebel
Add to calendarSession highlights:
- PASCAL Precision system: delivering targeted repair.
- Different needs, one solution: versatility of the PASCAL Precision system.
- Transseptal mitral valve replacement with the SAPIEN M3 system: simulation, case, and clinical evidence.
Day Case TAVI - The Future Standard Of Care For Most TAVI patients
Sunday 16 November 2025 | 17:15-18:15 | Room Westminster
Anchorperson: Sam Dawkins
Spokesperson: Clare Appleby
Discussants: Iqbal Malik, Seth Vijayan, Francesco Saia, Sandra Lauck, Gemma McCalmont
Add to calendarSession highlights:
- The UK’s day case TAVI model: what it is and how it may be adapted in your centre.
- Why day case TAVI is relevant in the current context and what it takes to make it work.
- Benefits and risks of same-day discharge from the patient perspective.
Symposia
Hot Topics in Structural Heart: Addressing Patients’ Unmet Needs With EVOQUE TTVR and SAPIEN THV-in-THV
Monday 17 November 2025 | 11:20-12:50 | Main Arena
Anchorperson: Michael Joner
Spokespersons: Giuseppe Tarantini, Philipp Bartko
Discussants: Radoslaw Parma, Eike Tigges, Christian Besler, Thomas Cuisset, Georg Nickenig
Procedural Analyst: Alison Duncan
Add to calendarSession highlights:
- Latest information and European data on redo TAVI techniques.
- TAVI planning for lifetime valve management and reintervention.
- Optimizing Patient Selection: Insights from Real-World Use of the EVOQUE System.
- In action – Two educational live cases from the Heart and Diabetes Center NRW, Bad Oeynhausen (DE) featuring the SAPIEN 3 and the EVOQUE valves.
Advancing Structural Heart with 3D ICE and Device Guidance
Co-sponsored by Philips
Monday 17 November 2025 | 16:40-17:40 | Room Thames
Anchorperson: Nina Wunderlich
Spokesperson: Victoria Delgado
Add to calendarSession highlights:
- Imaging innovations and perspectives.
- Philips Device Guide in mitral TEER procedure with PASCAL Ace implant.
- Live Case from the Heart and Diabetes Center NRW, Bad Oeynhausen (DE) featuring the VeriSight Pro 3D ICE Catheter and the PASCAL Precision system for tricuspid TEER.
Symposium
TAVI In 2025: Transforming Care With The New Valvular Heart Disease Guidelines
Tuesday 18 November 2025 | 11:10-12:40 | Main Arena
Anchorperson: Christopher Cook
Spokesperson: Martin Leon
Discussants: Philippe Genereux, Philippe Pibarot, Francesco Saia, Axel Unbehaun, Kentaro Hayashida
Procedural Analyst: Radoslaw Parma
Add to calendarSession highlights:
- Impact of the 2025 VHD guidelines on reshaping TAVI care.
- Shift in managing severe aortic stenosis.
- Global insights on the growing TAVI population.
Experience More with our Training Village Activities
Get hands-on, explore different scenarios, and sharpen your skills in a dynamic, interactive setting.
Visit our Training Village for:
- THV-in-THV applications with the SAPIEN platform
- EVOQUE implant TTVR Room
- PASCAL implant TEER Room
- SAPIEN M3 system TMVR Room
THV Training Village
Get hands-on with real-life THV-in-THV cases guided by experienced Interventional Cardiologists. Practice different scenarios on a simulator and sharpen your skills in a dynamic, interactive setting.
TV Faculty: Dr Davide Gabbieri, Dr Myriam Akodad, Dr Radoslaw Parma, Dr Luis Nombela, Dr Luca Nai Fovino
16 November 2025: 11:00 - 12:45 | 13:30 - 15:15 | 16:00 - 17:45
17 November 2025: 10:00 - 11:45 | 13:00 - 14:45 | 15:30 - 17:15
18 November 2025: 09:00 - 10:45
TMTT Training Village
Join the Heart Team discussion and explore our portfolio of therapies for mitral and tricuspid regurgitation through hands-on sessions.
Workshop 1
Optimizing Mitral Valve Therapy: Navigating the Edwards Portfolio
16 November 2025: 13:00 - 13:45
17 November 2025: 10:30 - 11:15 | 16:30 – 17:15
18 November 2025: 10:00 - 10:45
Workshop 2
Optimizing Tricuspid Valve Therapy: Navigating the Edwards Portfolio
16 November 2025: 11:15 - 12:00
17 November 2025: 09:00 - 09:45 | 12:00 – 12:45
18 November 2025: 08:30 - 09:15
Workshop 3
EVOQUE system in Action: Procedural Guidance and Benefits
16 November 2025: 13:00 – 13:45 | 14:30 – 15:15 | 16:00 – 16:45
17 November 2025: 10:30 – 11:15 | 13:30 – 14:15 | 15:00 – 15:45 | 16:30 – 17:15
18 November 2025: 10:00 – 10:45 | 11:30 – 12:15 | 13:15 – 14:00
Workshop 4
PASCAL implant system Mitral & Tricuspid Hands-On: Key Features and Procedural Benefits
16 November 2025: 13:00 – 13:45 | 14:30 – 15:15 | 16:00 – 16:45
17 November 2025: 10:30 – 11:15 | 13:30 – 14:15 | 15:00 – 15:45 | 16:30 – 17:15
18 November 2025: 10:00 – 10:45 | 11:30 – 12:15 | 13:15 – 14:00
Workshop 5
SAPIEN M3 system Immersive Experience: Therapy in Virtual Reality
16 November 2025: 11:15 – 12:00 | 14:30 – 15:15 | 16:00 – 16:45
17 November 2025: 09:00 – 09:45 | 12:00 – 12:45 | 13:30 – 14:15 | 15:00 – 15:45
18 November 2025: 08:30 – 09:15 | 11:30 – 12:15 | 13:15 – 14:00
Workshop 6 – In collaboration with 
Edwards Portfolio with GE Vivid Pioneer Imaging
16 November 2025: 17:15 – 18:00 MR
17 November 2025: 17:15 – 18:00 TR
Join us at our Booth (A9)
- Explore our latest technologies
- Delve into our clinical data
- Engage in in-depth conversations about our products, including the SAPIEN 3 Ultra RESILIA valve, the PASCAL Precision system, the EVOQUE system, and the SAPIEN M3 system
- Experience hands-on at our product stations
Silent Disco:
THV-in-THV case presentations from Lifetime Management Masters
17 November 2025: 10:00-10:30 | 16:30-17:00
Download our literature to learn more about our therapies
To receive a summary of our PCR London Valves 2025 activities, recordings, slide decks and future developments, join the Edwards Lifesciences community today.
heading 3
Content goes here
Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).
Clinical data on surgical valves with RESILIA tissue up to 7-year follow-up have been published, with additional follow-up to 10-years in progres.
References
- Beaver T, Bavaria JE, Griffith B, et al. Seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis. J Thorac Cardiovasc Surg. 2024 Sep;168(3):781-791